Retrospective Evaluation of Drug-Induced Cutaneous Adverse Reactions: Clinical Profile, Suspected Drugs, and Outcomes
International Journal of Pharmaceutical Quality Assurance · 30.11.2026 · 17 (11)
DOI: 10.25258/ijpqa.17.11.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.11.2026. Verfasst von Boddeda Moulidharan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Drug-induced cutaneous adverse reactions (CADRs) are among the most common adverse drug reactions, ranging from mild self-limiting eruptions to severe life-threatening conditions. Early identification of offending drugs is essential to minimize morbidity and improve patient outcomes.
Aim
To characterize the clinical spectrum, suspected drugs, management, and outcomes of CADRs in a tertiary care hospital. Methodology: A retrospective, observational, hospital-based study was performed in the Department of Dermatology, over a period of 9 months. from January 2026 to September 2026. Medical records of 120 patients diagnosed with CADRs were reviewed. Demographic characteristics, clinical manifestations, suspected drug groups, treatment modalities, and outcomes were analyzed using descriptive statistics.
Results
The calculated mean age was 42.8±17.6 years, with males comprising 56.7% of cases. Maculopapular rash (35.8%) was the most common presentation, followed by fixed drug eruption (18.3%) and urticaria (14.2%). Antibiotics (33.3%) and NSAIDs (23.3%) were the leading suspected drug groups. All patients underwent withdrawal of the offending medication, and 78.3% were administered oral antihistamines.. Complete recovery occurred in 54.2% of patients, with a mortality rate of 1.7%.
Conclusion
CADRs were predominantly associated with antibiotics and NSAIDs and generally had favorable outcomes following early drug withdrawal and appropriate management. Strengthening pharmacovigilance and rational prescriptions will drastically reduce the burden of CADRs.
Zitieren
APA
Moulidharan, B., Ghuman, R. K., & Choudhary, P. (2026). Retrospective Evaluation of Drug-Induced Cutaneous Adverse Reactions: Clinical Profile, Suspected Drugs, and Outcomes. International Journal of Pharmaceutical Quality Assurance, 17(11). https://doi.org/10.25258/ijpqa.17.11.9
Vancouver
Moulidharan B, Ghuman RK, Choudhary P. Retrospective Evaluation of Drug-Induced Cutaneous Adverse Reactions: Clinical Profile, Suspected Drugs, and Outcomes. International Journal of Pharmaceutical Quality Assurance. 2026;17(11). doi:10.25258/ijpqa.17.11.9
BibTeX
@article{Moulidharan2026,
author = {Moulidharan, Boddeda and Ghuman, Rajinderjit Kaur and Choudhary, Priyanka},
title = {Retrospective Evaluation of Drug-Induced Cutaneous Adverse Reactions: Clinical Profile, Suspected Drugs, and Outcomes},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {11},
doi = {10.25258/ijpqa.17.11.9}
}
EUVIMED